
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
The increasing resistance of bacteria towards all current classes of antibiotics is now a serious health problem in both developed and developing countries.Antibiotic Development and Resistance begins by reviewing the global status of bacterial infections and resistance. The chapters that follow describe the mechanisms involved, the spread of antibiotic resistance and its reversibility. An international team of authors addresses new theories and recent discoveries in bacterial resistance, including:*The role of antibiotic efflux mechanisms in resistance*The cost of resistance to bacteria*The importance of low-level resistance in the early development of clinically relevant resistanceThe final section of the book investigates modern techniques for the development of new drugs and highlights the importance of genomics and combinatorial chemistry in the search for new targets and antimicrobials.Ideal for clinical microbiologists, pathologists, infectious disease clinicians and researchers in medical microbiology and pharmaceutical sciences. Antibiotic Development and Resistance provides a comprehensive review of all aspects of resistance and addresses new concepts in the field of antibiotic development.
This text investigates the escalating global crisis of bacterial resistance to current antibiotic classes and explores the scientific methodologies required to develop effective new antimicrobial treatments. Edited by Diarmaid Hughes, the book compiles contributions from an international team of experts to analyze the biological mechanisms of resistance, the evolutionary costs to bacteria, and the potential for reversing these trends. The work bridges the gap between clinical observation and pharmaceutical innovation, providing a structured framework for understanding how genomics and combinatorial chemistry can identify novel drug targets.
What You Will Find
Experts identify this volume as a comprehensive resource for clinical microbiologists and pharmaceutical researchers seeking to understand the intersection of bacterial evolution and drug design. Readers frequently note the technical density of the prose, which serves as a foundational reference for professionals addressing infectious disease challenges.
Page Count:
270
Publication Date:
2004-01-01
Publisher:
Taylor & Francis Group Plc
ISBN-10:
0203346394
ISBN-13:
9780203346396
No comments yet. Be the first to share your thoughts!